#BioPharma-Synergy took place on 23rd -25th February 2021
The event is designed for the BD&Licensing pharma professionals focusing on BioSimilars, BioBetter & BioInnovative products. With an audience coming from Europe, LATAM, APAC, MENA & North America - BioPharma-Synergy invites dynamic pharma companies for three days of business partnering meetings and a content-driven programme.
In addition to B2B partnering the event offers a content-driven agenda
The 2021 conference programme focused on successful commercial strategies and pricing considerations, facilitating partnering across Geos between producers and buyers. Among the topics:
- Global Biosimilars/Biobetter outlook; key players and their market access strategies
- Regulatory approvals, tenders and pricing trends in Europe
- Opportunities and trends in biosimilars by region: APAC, MENA, CIS, LATAM and Europe
- Strategic considerations for biosimilar commercialisation
What do industry experts think about #BioPharmaSynergy?
Watch the highlights of the Buyers & Sellers discussion that took place at #BioPharmaSynergy 2021
[Form id="2"]
How to ensure you attend the next edition of the BioPharmaSynergy?